| Product NDC: | 49502-501 |
| Proprietary Name: | EpiPen Jr |
| Non Proprietary Name: | Epinephrine |
| Active Ingredient(s): | .15 mg/.3mL & nbsp; Epinephrine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49502-501 |
| Labeler Name: | Dey Pharma L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019430 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19871222 |
| Package NDC: | 49502-501-02 |
| Package Description: | 2 CONTAINER in 1 CARTON (49502-501-02) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS |
| NDC Code | 49502-501-02 |
| Proprietary Name | EpiPen Jr |
| Package Description | 2 CONTAINER in 1 CARTON (49502-501-02) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS |
| Product NDC | 49502-501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Epinephrine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19871222 |
| Marketing Category Name | NDA |
| Labeler Name | Dey Pharma L.P. |
| Substance Name | EPINEPHRINE |
| Strength Number | .15 |
| Strength Unit | mg/.3mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |